https___www.dubaieye1038.com_news_international_worlds-first-malaria-vaccine-gets-who-backing-for-africa_.xml
https___satkarpost.com_2020_08_12_24261__1.xml
1.1 2.1 3.1 4.1 5.1 6.1 7.1 7.2
The World Health Organisation (WHO) on Wednesday said the only approved vaccine against malaria should be widely used on African children. It's potentially a major advance against a disease that kills hundreds of thousands of people annually. The recommendation is for RTS,S, or Mosquirix, a vaccine developed by British drugmaker GlaxoSmithKline. It was jointly announced in Geneva by the WHO's top advisory bodies for malaria and immunization, the Malaria Policy Advisory Group and the Strategic Advisory Group of Experts on Immunisation. The WHO's endorsement is a crucial step for getting more investment in the production and rollout of the shot. This recommendation is based on results from an ongoing pilot programme in Ghana, Kenya and Malawi. "This long-awaited #malaria vaccine is a breakthrough for science, child health and malaria control. Using this vaccine in addition to existing tools to prevent malaria could save tens of thousands of young lives each year"-@DrTedros #EndMalaria https://t.co/Y2z8pFe2Xx— World Health Organization (WHO) (@WHO) October 6, 2021
1.1 2.1 3.1 4.1
एजेन्सी, २८ साउनः विश्व स्वास्थ्य संगठन (डब्ल्यूएचओ) ले रुसले विकसित गरेको भ्याक्सिनको मूल्यांकन गर्न यसबारे केही जानकारी नभएको बताएको छ । विश्व स्वास्थ्य संगठनअन्तर्गत पर्ने पेन–अमेरिकन हेल्थ अर्गनाइजेशनका सहायक निर्देशक जरबास बारबोसाले भने, ‘ब्राजिलले भ्याक्सिन बनाउन सुरु गर्नेछ भन्ने सुनेको छु । तर जबसम्म थप ट्रायल पूरा हुँदैन तबसम्म यस्तो गर्न हुँदैन ।’ भ्याक्सिन बनाउने जो सुकैले पनि यो प्रक्रियाको पालना गर्नुपर्छ र भ्याक्सिन सुरक्षित भएको र विश्व स्वास्थ्य संगठनले सिफारिश गरेको भनेर सुनिश्चित गर्नुपर्छ । गत हप्ता विश्व स्वास्थ्य संगठनले रुसलाई कोरोनाविरुद्धको भ्याक्सिन बनाउनका लागि अन्तर्राष्ट्रिय दिशानिर्देशको पालना गर्न आग्रह गरेको थियो ।